Literature DB >> 8655682

Pathology of deaths associated with "ecstasy" and "eve" misuse.

C M Milroy1, J C Clark, A R Forrest.   

Abstract

AIMS: To study the postmortem pathology associated with ring substituted amphetamine (amphetamine derivatives) misuse.
METHODS: The postmortem findings in deaths associated with the ring substituted amphetamines 3,4-methylenedioxymethyl-amphetamine (MDMA, ecstasy) and 3,4-methylenedioxyethylamphetamine (MDEA, eve) were studied in seven young white men aged between 20 and 25 years.
RESULTS: Striking changes were identified in the liver, which varied from foci of individual cell necrosis to centrilobular necrosis. In one case there was massive hepatic necrosis. Changes consistent with catecholamine induced myocardial damage were seen in five cases. In the brain perivascular haemorrhagic and hypoxic changes were identified in four cases. Overall, the changes in four cases were the same as those reported in heart stroke, although only two cases had a documented history of hyperthermia. Of these four cases, all had changes in their liver, three had changes in their brains, and three in their heart. Of the other three cases, one man died of fulminant liver failure, one of water intoxication and one probably from a cardiac arrhythmia associated with myocardial fibrosis.
CONCLUSIONS: These data suggest that there is more than one mechanism of damage in ring substituted amphetamine misuse, injury being caused by hyperthermia in some cases, but with ring substituted amphetamines also possibly having a toxic effect on the liver and other organs in the absence of hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655682      PMCID: PMC500349          DOI: 10.1136/jcp.49.2.149

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

1.  Survival following 'Ecstasy' ingestion with a peak temperature of 42 degrees C.

Authors:  A S Logan; B Stickle; N O'Keefe; H Hewitson
Journal:  Anaesthesia       Date:  1993-11       Impact factor: 6.955

2.  Hyponatraemia and catatonic stupor after taking "ecstasy".

Authors:  D L Maxwell; M I Polkey; J A Henry
Journal:  BMJ       Date:  1993-11-27

3.  Hyponatraemia after ingestion of ecstasy.

Authors:  B Kessel
Journal:  BMJ       Date:  1994-02-05

4.  Subarachnoid haemorrhage associated with MDMA abuse.

Authors:  J A Gledhill; D F Moore; D Bell; J A Henry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

5.  Cerebral venous sinus thrombosis induced by 'ecstasy'.

Authors:  P M Rothwell; R Grant
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

6.  Ecstasy intoxication: appreciation of complications and the role of dantrolene.

Authors:  C Webb; V Williams
Journal:  Anaesthesia       Date:  1993-06       Impact factor: 6.955

7.  Cerebral infarction in association with Ecstasy abuse.

Authors:  S Manchanda; M J Connolly
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

8.  Intracranial haemorrhage associated with ingestion of 'ecstasy'.

Authors:  J C Hughes; M McCabe; R J Evans
Journal:  Arch Emerg Med       Date:  1993-12

9.  'Ecstasy' ingestion: a case report of severe complications.

Authors:  P J Barrett; G T Taylor
Journal:  J R Soc Med       Date:  1993-04       Impact factor: 18.000

10.  'Ecstasy' induced pneumomediastinum.

Authors:  A J Levine; S Drew; G M Rees
Journal:  J R Soc Med       Date:  1993-04       Impact factor: 18.000

View more
  31 in total

Review 1.  Ten years of 'ecstasy'.

Authors:  C M Milroy
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

Review 2.  Recreational drug misuse: issues for the cardiologist.

Authors:  A Ghuran; J Nolan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

3.  Ecstasy induced acute myocardial infarction.

Authors:  A Qasim; J Townend; M K Davies
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

4.  CYP2D6 deficiency, a factor in ecstasy related deaths?

Authors:  T C Gilhooly; A K Daly
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 5.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

6.  Ecstasy-induced myocardial infarction in a teenager: rare complication of a widely used illicit drug.

Authors:  Michael Möller; Jens Völz; Robert Paliege; Corinna Lenz; Rainer Gradaus; Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

7.  Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

Authors:  Sylvia K Shenouda; Kurt J Varner; Felix Carvalho; Pamela A Lucchesi
Journal:  Cardiovasc Toxicol       Date:  2009-03-31       Impact factor: 3.231

8.  Muscle changes in the neuroleptic malignant syndrome.

Authors:  W M Behan; M Madigan; B J Clark; J Goldberg; D R McLellan
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 9.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

10.  Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users.

Authors:  Praveen Kanneganti; Marilyn A Huestis; Erin A Kolbrich; Robert Goodwin; Roy C Ziegelstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.